Epix president resigns

Epix Pharmaceuticals president and head of research and development Dr. Andrew Uprichard has resigned to pursue other opportunities.

Uprichard had been president and head of research and development at the Lexington, MA-based MR contrast developer since 2006. He will continue to assist Epix as a consultant, according to the company.

Related Reading

Epix to resubmit NDA for Vasovist, April 24, 2008

Epix reaches agreement with FDA over Vasovist, February 1, 2008

Epix to raise $16.3 million, November 12, 2007

Epix receives FDA response, June 19, 2007

Epix posts big Q1 loss, May 9, 2007

Copyright © 2008 AuntMinnie.com

Page 1 of 610
Next Page